EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review

Mina Shahisavandi, Kan Wang iD, Mohsen Ghanbari iD, Fariba Ahmadizar iD

Genes · 2023

DOI: 10.3390/genes14071464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Mina Shahisavandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spectrum of information related to precision medicine in diabetes generally includes clinical data, genetics, and omics-based biomarkers that can guide personalized decisions on diabetes care. Given the remarkable progress in patient risk characterization, there is particular interest in using molecular biomarkers to guide diabetes management. Metabolomics is an emerging molecular approach that helps better understand the etiology and promises the identification of novel biomarkers for complex diseases. Both targeted or untargeted metabolites extracted from cells, biofluids, or tissues can be investigated by established high-throughput platforms, like nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Metabolomics is proposed as a valuable tool in precision diabetes medicine to discover biomarkers for diagnosis, prognosis, and management of the progress of diabetes through personalized phenotyping and individualized drug-response monitoring. This review offers an overview of metabolomics knowledge as potential biomarkers in type 2 diabetes mellitus (T2D) diagnosis and the response to glucose-lowering medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HumansGlucoseMetabolomicsBiomarkersMass Spectrometry

Stichwörter der Autor:innen

glucose-lowering medicationsmedicationsmetabolitesmetabolomicstype 2 diabetes mellitus

Substanzen

GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.

ORCID-Profile: Kan Wang, Mohsen Ghanbari, Fariba Ahmadizar

Zitieren

APA

Shahisavandi, M., Wang, K., Ghanbari, M., & Ahmadizar, F. (2023). Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review. Genes. https://doi.org/10.3390/genes14071464

Vancouver

Shahisavandi M, Wang K, Ghanbari M, Ahmadizar F. Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review. Genes. 2023. doi:10.3390/genes14071464

BibTeX
@article{Shahisavandi2023,
  author = {Shahisavandi, Mina and Wang, Kan and Ghanbari, Mohsen and Ahmadizar, Fariba},
  title = {Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14071464}
}
Kostenlos starten →